The Drug Information Association (DIA) India is planning to organize its 8th annual conference at NIMHANS Convention Center in Bangalore from October 24 to 26, 2013.

The main aim of this annual meet is to provide a forum for academia, industry, regulators and researchers to come together to discuss the new and evolving environment for healthcare product development in India. The forum also aims at deliberating on the contemporary issues, future challenges and growth opportunities for the pharmaceutical and healthcare industry.

The conference is expected to attract more than 400 delegates from across the country. The organizers are planning to feature four tracks with 28 sessions and plenaries on key themes in drug discovery, clinical development, technology-enabled services, medical writing, biostatistics and commercialization during the event.

This time DIA India is roping in more than 90 renowned experts from India and abroad to deliberate on key issues related to the new pharmaceutical regulatory environment. Prominent among them include Padma Shri Prof. Ranjit Roy Chaudhury, national professor of Pharmacology and chairman of the Task Force for Research at Apollo Hospitals Group, and Mukhtar Ahmed, Oracle HSGBU’s vice president of Product Strategy.

Highlighting the present scenario of the pharmaceutical industry in India, Organizers at DIA observed, “We are witnessing a time of momentous change in the pharmaceutical industry in India. New regulations have made the pursuit of clinical development in the region extremely challenging, while demand for services in the regulation-free domains of remote data processing and IT-enabled offerings is growing at an unprecedented scale. A section of the Indian pharmaceutical industry is at the threshold of entry into uncharted territories with global development of innovative assets and biosimilars, even as it braces for headwinds from a struggling global economy and more demanding regulatory requirements.”